Health
DBV Technologies
DBV Technologies is a global clinical stage biopharmaceutical company developing innovative products for the diagnosis and treatment of food allergies
Status
Dual IPO on Euronext (DBV) & Nasdaq (DBVT)
Active
Other investors
Sofinnova Partners, Apax Partners, InnoBio Fund, Lundbeckfonden
